gp130/IL-6 binding inhibitor peptide (Interprotein)

N/A

Report date: 2025/03/20 15:11:16

Base Information

Drug Namegp130/IL-6 binding inhibitor peptide (Interprotein)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIL-6 receptor antagonistsAminopeptidase N inhibitors
TargetsIL-6 receptorAminopeptidase N
Therapy Area/IndicationsInflammationAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInterprotein Corp
China Registration ClassN/A

Develop Information

Active CompaniesInterprotein Corp
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A